61 - Comparable Efficacy of Once-Weekly Subcutaneous Semaglutide in Subjects With Type 2 Diabetes Aged <65 and ≥65 Years: SUSTAIN 1–5 and 7–10 Posthoc Analysis

Publication date: October 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 7, SupplementAuthor(s): Akshay Jain, Mark L. Warren, Charlotte Hindsberger, Jack Lawson, Bernhard Ludvik, Sascha Pilemann-Lyberg, Adie Viljoen
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research